Tsung Lun Lee

Dr. Tsung Lun Lee

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2022 in Neoplasia
Verified
Journal Article
Open access
TLTsung Lun Lee
Tsung Lun Lee
TCTien-Hua Chen
Tien-Hua Chen
YKYing-Ju Kuo
Ying-Ju Kuo
HLHsin-Yi Lan
Hsin-Yi Lan
Muh-Hwa YangMuh-Hwa Yang
Muh-Hwa Yang
PCPen-Yuan Chu
Pen-Yuan Chu
• Tumor-associated tissue eosinophilia (TATE)-enriched head and neck squamous cell carcinoma (HNSCC) is correlated with aggressive pathological features and poor prognosis. • TATE induces HNSCC metastasis through CCL2 release. • TATE increases angiogenesis in neighboring HNSCC. • TATE coexists with immunosuppressive tumor microenvironment in HNSCC.

1 October 2019 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
TLTsung Lun Lee
Tsung Lun Lee
PCPo‐Hsien Chiu
Po‐Hsien Chiu
WLWing‐Yin Li
Wing‐Yin Li
MYMuh‐Hwa Yang
Muh‐Hwa Yang
PWPei‐Yin Wei
Pei‐Yin Wei
TSTai Shyh-Kuan
Tai Shyh-Kuan

6 January 2011 in Head & Neck
Verified
Journal Article
Closed access
PDF file
PCPen‐Yuan Chu
Pen‐Yuan Chu
TLTsung Lun Lee
Tsung Lun Lee
SCShyue‐Yih Chang
Shyue‐Yih Chang

26 October 2017 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
YLYen-Ting Lu
Yen-Ting Lu
TSTai Shyh-Kuan
Tai Shyh-Kuan
TLTsung Lun Lee
Tsung Lun Lee

31 October 2025 in Laboratory Investigation
Verified
Journal Article
Closed access
YHYu-Wen Huang
Yu-Wen Huang
YKYing-Ju Kuo
Ying-Ju Kuo
MCMing-Chi Chen
Ming-Chi Chen
JRJackson Rodrigues
Jackson Rodrigues
TLTsung Lun Lee
Tsung Lun Lee
Muh-Hwa YangMuh-Hwa Yang
Muh-Hwa Yang

1 October 2016 in Journal of the Chinese Medical Association
Verified
Journal Article
Open access
YCYun-Ting Chao
Yun-Ting Chao
LWLing-Wei Wang
Ling-Wei Wang
PCPen-Yuan Chu
Pen-Yuan Chu
Muh-Hwa YangMuh-Hwa Yang
Muh-Hwa Yang
YHYen-Bin Hsu
Yen-Bin Hsu
STShyh-Kuan Tai
Shyh-Kuan Tai
Ve review was performed in 66 patients with T1-T2 tonsillar SCCs treated by CRT from 1997 to 2009. The efficacy of pre-CRT tonsillectomy was analyzed with regard to oncological and functional outcomes. Results Thirty patients (45.5%) received tonsillectomy (pre-CRT tonsillectomy group), and 36 patients (54.5%) did not (CRT group). Except for a trend toward more T1 cases (33.3% vs. 13.9%, p = 0.061) and significantly less chemotherapy use (60% vs. 86.1%, p = 0.016) in the pre-CRT tonsillectomy group, there were no differences between the two groups in terms of age, gender, N classification (nodal status), overall stage, radiation dose, duration, or technique. In the pre-CRT tonsillectomy group, eight cases (26.7%) achieved an adequate operative margin judged by the surgeon, and only one (12.5%) had a negative pathological margin. In long-term follow-up, there were no statistically significant differences between the two groups regarding local (93.3% vs. 91.7%, p = 0.82) or regional control (93.3% vs. 94.4%, p = 0.84). The pre-CRT tonsillectomy group did not have a better 5-year disease-specific survival rate (83.3% vs. 94.4%, p = 0.177) or 5-year overall survival rate (70% vs. 94.4%, p = 0.017). There were no differences in complications or functional results (feeding tube and tracheostomy dependence), and quality of life demonstrated no significant difference. Conclusion Pre-CRT tonsillectomy contributes little to oncological and functional outcomes in patients with T1-T2 tonsillar SCC....